PATENT CLAIM ANALYSIS

Application Number: 15899867
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "563000"]

Abstract:
Described herein are compounds that are EP 4  agonists and antagonists which are useful for treating a variety of pathological conditions associated with activity of EP 4  receptors.

Claim (Index 12):
A method of treating glaucoma, the method comprising administering an effective amount of the compound of  claim 10  to an individual in need thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.20833
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15316786', '13003780', '13760726', '15524298', '14682179']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6910451351772736
- 35 USC 102 Novelty (BERT): 0.544628800463123
- Combined Prediction Score: 0.6764035017058585
- Mean Citation Score: 240.529486
- Max Citation Score: 376.9491
- Similarity Product: 301.8845974667788

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test